| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyloid beta-Peptides | 76 | 2023 | 3574 | 5.360 |
Why?
|
| Alzheimer Disease | 93 | 2024 | 7988 | 5.350 |
Why?
|
| Alzheimer Vaccines | 12 | 2020 | 25 | 4.530 |
Why?
|
| Amyloid beta-Protein Precursor | 29 | 2021 | 1121 | 2.850 |
Why?
|
| Plaque, Amyloid | 25 | 2022 | 729 | 2.850 |
Why?
|
| Pyrrolidonecarboxylic Acid | 7 | 2021 | 65 | 2.510 |
Why?
|
| Presenilin-1 | 17 | 2021 | 635 | 1.830 |
Why?
|
| Down Syndrome | 14 | 2021 | 880 | 1.610 |
Why?
|
| Iron Radioisotopes | 2 | 2021 | 21 | 1.550 |
Why?
|
| Peptide Fragments | 24 | 2021 | 5095 | 1.400 |
Why?
|
| Mice, Transgenic | 37 | 2023 | 9735 | 1.270 |
Why?
|
| Complement C3 | 3 | 2017 | 460 | 1.250 |
Why?
|
| Immunization, Passive | 7 | 2020 | 625 | 1.220 |
Why?
|
| Microglia | 11 | 2023 | 1261 | 1.100 |
Why?
|
| Immunization | 8 | 2013 | 1255 | 0.970 |
Why?
|
| Aging | 16 | 2018 | 8626 | 0.940 |
Why?
|
| Hippocampus | 13 | 2023 | 3661 | 0.930 |
Why?
|
| Immunotherapy | 11 | 2020 | 4414 | 0.800 |
Why?
|
| Disease Models, Animal | 32 | 2021 | 18006 | 0.790 |
Why?
|
| Insulysin | 2 | 2020 | 50 | 0.770 |
Why?
|
| Gamma Rays | 1 | 2021 | 320 | 0.740 |
Why?
|
| Antibody Formation | 11 | 2013 | 1402 | 0.720 |
Why?
|
| Nerve Degeneration | 3 | 2017 | 748 | 0.720 |
Why?
|
| Brain | 41 | 2022 | 26343 | 0.720 |
Why?
|
| Blood-Brain Barrier | 5 | 2022 | 1015 | 0.710 |
Why?
|
| Neuroglia | 5 | 2020 | 925 | 0.650 |
Why?
|
| Antibodies, Monoclonal | 7 | 2020 | 9274 | 0.630 |
Why?
|
| Gliosis | 5 | 2017 | 243 | 0.630 |
Why?
|
| Animals | 87 | 2023 | 168561 | 0.620 |
Why?
|
| Cognition Disorders | 7 | 2016 | 4030 | 0.610 |
Why?
|
| Behavior, Animal | 4 | 2021 | 1882 | 0.610 |
Why?
|
| Antibodies | 11 | 2016 | 2459 | 0.590 |
Why?
|
| Space Flight | 1 | 2019 | 184 | 0.590 |
Why?
|
| Neuroprotective Agents | 6 | 2013 | 941 | 0.580 |
Why?
|
| Amyloid | 6 | 2021 | 795 | 0.580 |
Why?
|
| Mice | 52 | 2023 | 81045 | 0.570 |
Why?
|
| Sesquiterpenes | 2 | 2007 | 175 | 0.550 |
Why?
|
| Benzofurans | 3 | 2010 | 140 | 0.510 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 14 | 2015 | 3862 | 0.490 |
Why?
|
| Carbazoles | 1 | 2015 | 226 | 0.480 |
Why?
|
| Receptors, GABA | 1 | 2015 | 288 | 0.470 |
Why?
|
| Synapses | 10 | 2018 | 1724 | 0.470 |
Why?
|
| Vaccination | 5 | 2019 | 3256 | 0.470 |
Why?
|
| Diphtheria Toxoid | 1 | 2013 | 28 | 0.460 |
Why?
|
| Complement System Proteins | 3 | 2024 | 795 | 0.460 |
Why?
|
| Phagocytosis | 5 | 2020 | 1538 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 18 | 2019 | 21821 | 0.450 |
Why?
|
| Complement C3c | 1 | 2012 | 7 | 0.430 |
Why?
|
| Fluorine Radioisotopes | 1 | 2015 | 448 | 0.430 |
Why?
|
| Macrophage-1 Antigen | 2 | 2016 | 290 | 0.420 |
Why?
|
| Immunoglobulin G | 8 | 2022 | 4554 | 0.400 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2585 | 0.390 |
Why?
|
| Maze Learning | 5 | 2015 | 478 | 0.380 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 3639 | 0.380 |
Why?
|
| Vaccines | 5 | 2006 | 817 | 0.370 |
Why?
|
| Adjuvants, Immunologic | 3 | 2005 | 1000 | 0.360 |
Why?
|
| Complement Activation | 2 | 2024 | 452 | 0.360 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2023 | 876 | 0.350 |
Why?
|
| Antibody Specificity | 5 | 2006 | 1094 | 0.350 |
Why?
|
| Antigens | 2 | 2009 | 1462 | 0.330 |
Why?
|
| Saguinus | 1 | 2008 | 17 | 0.330 |
Why?
|
| Mice, Inbred DBA | 5 | 2019 | 642 | 0.310 |
Why?
|
| Enterotoxins | 3 | 2006 | 368 | 0.310 |
Why?
|
| Administration, Intranasal | 7 | 2006 | 446 | 0.310 |
Why?
|
| Genotype | 2 | 2021 | 12946 | 0.300 |
Why?
|
| Central Nervous System | 3 | 2024 | 1354 | 0.290 |
Why?
|
| Cognition | 4 | 2021 | 6722 | 0.290 |
Why?
|
| Epitope Mapping | 4 | 2013 | 311 | 0.280 |
Why?
|
| Neurons | 15 | 2017 | 9325 | 0.270 |
Why?
|
| Escherichia coli Proteins | 4 | 2006 | 1052 | 0.260 |
Why?
|
| Minocycline | 1 | 2006 | 163 | 0.250 |
Why?
|
| Humans | 89 | 2024 | 742088 | 0.250 |
Why?
|
| Cerebral Cortex | 10 | 2017 | 5705 | 0.240 |
Why?
|
| Bacterial Toxins | 3 | 2006 | 933 | 0.230 |
Why?
|
| Apolipoproteins E | 3 | 2023 | 1438 | 0.230 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2020 | 1989 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 6 | 2012 | 4465 | 0.230 |
Why?
|
| Apolipoprotein E4 | 2 | 2021 | 667 | 0.220 |
Why?
|
| Memory Disorders | 3 | 2018 | 1183 | 0.220 |
Why?
|
| Neurofibrillary Tangles | 5 | 2016 | 437 | 0.220 |
Why?
|
| Imidazolines | 1 | 2021 | 18 | 0.210 |
Why?
|
| Complement C1q | 4 | 2020 | 92 | 0.210 |
Why?
|
| tau Proteins | 5 | 2016 | 1860 | 0.200 |
Why?
|
| Statistics, Nonparametric | 3 | 2013 | 2885 | 0.200 |
Why?
|
| Immunity, Cellular | 2 | 2005 | 1606 | 0.200 |
Why?
|
| Cytokines | 6 | 2017 | 7317 | 0.200 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 972 | 0.200 |
Why?
|
| Neuronal Plasticity | 5 | 2015 | 1418 | 0.200 |
Why?
|
| Aminoacyltransferases | 1 | 2021 | 51 | 0.200 |
Why?
|
| Amyloid Precursor Protein Secretases | 7 | 2007 | 584 | 0.200 |
Why?
|
| Cathepsins | 4 | 2004 | 239 | 0.190 |
Why?
|
| Endopeptidases | 6 | 2006 | 772 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 1525 | 0.180 |
Why?
|
| Time Factors | 10 | 2021 | 40054 | 0.180 |
Why?
|
| Epitopes | 5 | 2020 | 2569 | 0.180 |
Why?
|
| Transfection | 4 | 2013 | 5892 | 0.180 |
Why?
|
| Societies | 1 | 2020 | 104 | 0.180 |
Why?
|
| Male | 38 | 2023 | 349538 | 0.180 |
Why?
|
| Complement C4b | 1 | 2000 | 135 | 0.170 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6259 | 0.170 |
Why?
|
| Synaptophysin | 3 | 2016 | 141 | 0.170 |
Why?
|
| Mice, Knockout | 7 | 2017 | 14554 | 0.170 |
Why?
|
| Clinical Trials as Topic | 6 | 2018 | 7901 | 0.170 |
Why?
|
| Aspartic Acid Endopeptidases | 6 | 2007 | 311 | 0.160 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2021 | 694 | 0.160 |
Why?
|
| Species Specificity | 4 | 2017 | 2479 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 3 | 2017 | 1060 | 0.160 |
Why?
|
| Membrane Proteins | 11 | 2016 | 7873 | 0.160 |
Why?
|
| Immunohistochemistry | 13 | 2015 | 11363 | 0.150 |
Why?
|
| Blotting, Western | 7 | 2009 | 5180 | 0.150 |
Why?
|
| Protons | 1 | 2023 | 1126 | 0.150 |
Why?
|
| ADAM Proteins | 2 | 2010 | 242 | 0.150 |
Why?
|
| Learning | 4 | 2019 | 1705 | 0.150 |
Why?
|
| Gene Expression | 3 | 2007 | 7790 | 0.150 |
Why?
|
| Education | 1 | 2019 | 543 | 0.140 |
Why?
|
| Age Factors | 7 | 2016 | 18355 | 0.140 |
Why?
|
| Benzimidazoles | 1 | 2021 | 848 | 0.140 |
Why?
|
| Inflammation | 7 | 2023 | 10578 | 0.140 |
Why?
|
| Immunity | 1 | 2022 | 1011 | 0.140 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6365 | 0.140 |
Why?
|
| Alkaloids | 2 | 2007 | 190 | 0.140 |
Why?
|
| Synapsins | 1 | 2015 | 43 | 0.130 |
Why?
|
| Synaptosomes | 1 | 2015 | 115 | 0.130 |
Why?
|
| Fear | 2 | 2015 | 1436 | 0.130 |
Why?
|
| Solubility | 1 | 2017 | 1083 | 0.130 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2015 | 135 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 742 | 0.130 |
Why?
|
| Amyloidosis | 3 | 2012 | 795 | 0.130 |
Why?
|
| Female | 30 | 2023 | 379592 | 0.120 |
Why?
|
| Research Personnel | 1 | 2019 | 573 | 0.120 |
Why?
|
| Immunoprecipitation | 3 | 2013 | 905 | 0.120 |
Why?
|
| Point Mutation | 2 | 1997 | 1624 | 0.120 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2013 | 524 | 0.120 |
Why?
|
| CHO Cells | 3 | 2013 | 1407 | 0.120 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 1368 | 0.120 |
Why?
|
| Nootropic Agents | 1 | 2015 | 160 | 0.120 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 270 | 0.120 |
Why?
|
| Escherichia coli | 2 | 2005 | 4214 | 0.120 |
Why?
|
| Random Allocation | 1 | 2019 | 2425 | 0.120 |
Why?
|
| Phenotype | 5 | 2017 | 16331 | 0.120 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2015 | 377 | 0.120 |
Why?
|
| Cell Survival | 5 | 2017 | 5872 | 0.120 |
Why?
|
| Cosmic Radiation | 1 | 2012 | 12 | 0.110 |
Why?
|
| Cricetinae | 3 | 2013 | 2471 | 0.110 |
Why?
|
| Dogs | 3 | 2018 | 3910 | 0.110 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 3800 | 0.110 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2013 | 370 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 5 | 2002 | 1799 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2016 | 541 | 0.110 |
Why?
|
| Immunization, Secondary | 2 | 2006 | 340 | 0.110 |
Why?
|
| Mutation | 7 | 2023 | 29717 | 0.110 |
Why?
|
| Drug Discovery | 2 | 2018 | 1057 | 0.110 |
Why?
|
| Neuroblastoma | 3 | 2010 | 1225 | 0.110 |
Why?
|
| Optic Nerve | 1 | 1996 | 548 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10943 | 0.100 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2012 | 54 | 0.100 |
Why?
|
| Age of Onset | 4 | 2013 | 3266 | 0.100 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 533 | 0.100 |
Why?
|
| Brain Chemistry | 4 | 2006 | 981 | 0.100 |
Why?
|
| Phosphorylation | 6 | 2020 | 8436 | 0.100 |
Why?
|
| Astrocytes | 3 | 2017 | 1266 | 0.100 |
Why?
|
| Research | 1 | 2020 | 1999 | 0.100 |
Why?
|
| Microinjections | 1 | 2012 | 326 | 0.100 |
Why?
|
| Receptors, Complement | 1 | 2012 | 264 | 0.100 |
Why?
|
| Cerebellum | 3 | 2000 | 1490 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 1423 | 0.100 |
Why?
|
| Lysosomes | 2 | 2012 | 893 | 0.100 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 898 | 0.090 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2013 | 855 | 0.090 |
Why?
|
| Malondialdehyde | 1 | 2010 | 104 | 0.090 |
Why?
|
| S-Adenosylmethionine | 1 | 2012 | 212 | 0.090 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 364 | 0.090 |
Why?
|
| Spatial Behavior | 1 | 2010 | 90 | 0.090 |
Why?
|
| Maleimides | 1 | 2010 | 112 | 0.090 |
Why?
|
| Nerve Regeneration | 1 | 1996 | 791 | 0.090 |
Why?
|
| Long-Term Potentiation | 4 | 2016 | 293 | 0.090 |
Why?
|
| Infusions, Parenteral | 2 | 2015 | 415 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2015 | 1124 | 0.090 |
Why?
|
| Motor Activity | 1 | 2019 | 2714 | 0.080 |
Why?
|
| Exosomes | 1 | 2013 | 412 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2024 | 23387 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2013 | 10472 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1310 | 0.080 |
Why?
|
| Infusion Pumps | 1 | 2009 | 163 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2010 | 16665 | 0.080 |
Why?
|
| Ligands | 2 | 2013 | 3293 | 0.080 |
Why?
|
| Dopamine | 2 | 2007 | 1589 | 0.080 |
Why?
|
| Osteopetrosis | 1 | 2007 | 43 | 0.080 |
Why?
|
| Disease Progression | 5 | 2018 | 13256 | 0.080 |
Why?
|
| Tauopathies | 1 | 2012 | 307 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2004 | 1887 | 0.080 |
Why?
|
| Dementia | 2 | 2019 | 2501 | 0.070 |
Why?
|
| Aged | 18 | 2021 | 162944 | 0.070 |
Why?
|
| Receptors, Muscarinic | 1 | 2007 | 156 | 0.070 |
Why?
|
| Muscarinic Antagonists | 1 | 2007 | 137 | 0.070 |
Why?
|
| Encephalitis | 2 | 2006 | 423 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 2009 | 544 | 0.070 |
Why?
|
| Spleen | 1 | 2013 | 2359 | 0.070 |
Why?
|
| Cytoplasmic Granules | 1 | 2009 | 610 | 0.070 |
Why?
|
| T-Lymphocytes | 3 | 2013 | 10163 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 264 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3769 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2006 | 112 | 0.070 |
Why?
|
| Up-Regulation | 4 | 2016 | 4211 | 0.070 |
Why?
|
| G(M1) Ganglioside | 2 | 2004 | 99 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 480 | 0.070 |
Why?
|
| Interferon-gamma | 2 | 2004 | 3199 | 0.070 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2007 | 239 | 0.070 |
Why?
|
| Lipid A | 1 | 2005 | 67 | 0.070 |
Why?
|
| Memory | 3 | 2014 | 2163 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1613 | 0.070 |
Why?
|
| Sex Factors | 1 | 2019 | 10392 | 0.070 |
Why?
|
| Biophysical Phenomena | 1 | 2006 | 327 | 0.060 |
Why?
|
| Drug Interactions | 2 | 2008 | 1458 | 0.060 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 12071 | 0.060 |
Why?
|
| Biophysics | 1 | 2006 | 383 | 0.060 |
Why?
|
| Temporal Lobe | 3 | 2009 | 1669 | 0.060 |
Why?
|
| Apoptosis | 4 | 2017 | 9715 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 1866 | 0.060 |
Why?
|
| Rats, Wistar | 4 | 2013 | 1902 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2017 | 19223 | 0.060 |
Why?
|
| Rats | 10 | 2013 | 24265 | 0.060 |
Why?
|
| Administration, Cutaneous | 1 | 2006 | 711 | 0.060 |
Why?
|
| Interleukin-5 | 1 | 2004 | 273 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 3 | 2003 | 563 | 0.060 |
Why?
|
| Tandem Repeat Sequences | 1 | 2005 | 185 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 1801 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 3507 | 0.060 |
Why?
|
| Reference Values | 2 | 2002 | 4982 | 0.060 |
Why?
|
| Reaction Time | 1 | 2010 | 2092 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2006 | 495 | 0.060 |
Why?
|
| Synucleins | 1 | 2003 | 110 | 0.060 |
Why?
|
| Animals, Wild | 1 | 2003 | 92 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 379 | 0.060 |
Why?
|
| Cholera Toxin | 1 | 2005 | 553 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3861 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2007 | 3701 | 0.050 |
Why?
|
| Aged, 80 and over | 10 | 2017 | 57683 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1227 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3504 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2006 | 2723 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2003 | 309 | 0.050 |
Why?
|
| Gelsolin | 1 | 2003 | 190 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3081 | 0.050 |
Why?
|
| Indoles | 1 | 2010 | 1834 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 9639 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2002 | 428 | 0.050 |
Why?
|
| Longevity | 1 | 2009 | 1069 | 0.050 |
Why?
|
| Cell Line | 3 | 2006 | 15994 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2004 | 1146 | 0.050 |
Why?
|
| Lewy Body Disease | 1 | 2003 | 226 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2021 | 151 | 0.050 |
Why?
|
| Neocortex | 1 | 2004 | 400 | 0.050 |
Why?
|
| Middle Aged | 15 | 2017 | 213127 | 0.050 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2000 | 112 | 0.040 |
Why?
|
| Rhenium | 1 | 1999 | 13 | 0.040 |
Why?
|
| Colitis | 1 | 2008 | 1149 | 0.040 |
Why?
|
| Nasal Mucosa | 1 | 2002 | 373 | 0.040 |
Why?
|
| Clusterin | 1 | 2000 | 72 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 1546 | 0.040 |
Why?
|
| Complementarity Determining Regions | 1 | 2020 | 149 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2751 | 0.040 |
Why?
|
| Peptides | 2 | 2009 | 4392 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 686 | 0.040 |
Why?
|
| Complement C4 | 1 | 2000 | 257 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2012 | 3294 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2012 | 8297 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2002 | 680 | 0.040 |
Why?
|
| Haplorhini | 1 | 1999 | 551 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2009 | 1421 | 0.040 |
Why?
|
| Contusions | 1 | 2018 | 81 | 0.040 |
Why?
|
| Codon | 2 | 1997 | 611 | 0.040 |
Why?
|
| Cell Count | 2 | 2018 | 1831 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6608 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2017 | 8300 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 1999 | 195 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 3731 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 1333 | 0.040 |
Why?
|
| Dimerization | 2 | 2008 | 893 | 0.040 |
Why?
|
| Complement Pathway, Classical | 1 | 2016 | 97 | 0.030 |
Why?
|
| Tectum Mesencephali | 1 | 1996 | 20 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 1788 | 0.030 |
Why?
|
| Goldfish | 1 | 1996 | 65 | 0.030 |
Why?
|
| Bungarotoxins | 1 | 1996 | 46 | 0.030 |
Why?
|
| Immune Sera | 1 | 1996 | 641 | 0.030 |
Why?
|
| Axons | 1 | 1984 | 1681 | 0.030 |
Why?
|
| Horseradish Peroxidase | 1 | 1996 | 166 | 0.030 |
Why?
|
| Edema | 1 | 2020 | 790 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 1999 | 665 | 0.030 |
Why?
|
| Staining and Labeling | 2 | 1999 | 1099 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 112 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2001 | 1725 | 0.030 |
Why?
|
| Endocytosis | 1 | 2020 | 983 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1996 | 216 | 0.030 |
Why?
|
| Models, Biological | 3 | 2018 | 9581 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1996 | 494 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 1996 | 258 | 0.030 |
Why?
|
| Cricetulus | 2 | 2008 | 817 | 0.030 |
Why?
|
| Denervation | 1 | 1996 | 278 | 0.030 |
Why?
|
| Capillaries | 2 | 2015 | 774 | 0.030 |
Why?
|
| Hominidae | 1 | 1994 | 74 | 0.030 |
Why?
|
| Retinopathy of Prematurity | 1 | 1999 | 421 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2017 | 880 | 0.030 |
Why?
|
| PrPC Proteins | 1 | 2013 | 37 | 0.030 |
Why?
|
| Cholesterol | 1 | 2003 | 2895 | 0.030 |
Why?
|
| Neurites | 1 | 1996 | 380 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2004 | 8925 | 0.030 |
Why?
|
| Macrophages | 1 | 2008 | 5655 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17400 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 5519 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1996 | 670 | 0.030 |
Why?
|
| Child | 5 | 2006 | 77478 | 0.030 |
Why?
|
| Adolescent | 5 | 2006 | 85649 | 0.030 |
Why?
|
| Cytosol | 1 | 1996 | 901 | 0.030 |
Why?
|
| Pericytes | 1 | 2015 | 291 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2017 | 4282 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2013 | 147 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 1889 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2009 | 1539 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2013 | 3001 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 834 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2260 | 0.030 |
Why?
|
| Diffusion | 1 | 2013 | 832 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1994 | 657 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 454 | 0.020 |
Why?
|
| Adult | 10 | 2006 | 213712 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2013 | 534 | 0.020 |
Why?
|
| AIDS Dementia Complex | 1 | 1991 | 152 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2713 | 0.020 |
Why?
|
| Benzothiazoles | 2 | 2004 | 247 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 764 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 1992 | 492 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 2006 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 730 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2003 | 2774 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1301 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 2615 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2009 | 210 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6931 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2017 | 2257 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2009 | 437 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2009 | 160 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2502 | 0.020 |
Why?
|
| Monocytes | 1 | 2017 | 2593 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 7153 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 2009 | 279 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9387 | 0.020 |
Why?
|
| Macaca mulatta | 2 | 2004 | 2378 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14720 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1144 | 0.020 |
Why?
|
| Oxygen | 1 | 1999 | 4169 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2255 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2002 | 40955 | 0.020 |
Why?
|
| Dendritic Spines | 1 | 2008 | 233 | 0.020 |
Why?
|
| Primates | 1 | 2009 | 543 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2009 | 880 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 6974 | 0.020 |
Why?
|
| Haplotypes | 1 | 2012 | 2781 | 0.020 |
Why?
|
| Cathepsin L | 2 | 1995 | 75 | 0.020 |
Why?
|
| Leeches | 1 | 1984 | 11 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 3587 | 0.020 |
Why?
|
| Neprilysin | 1 | 2007 | 439 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 668 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 1727 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2008 | 469 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2004 | 319 | 0.010 |
Why?
|
| RNA Interference | 1 | 2013 | 2890 | 0.010 |
Why?
|
| Thiazoles | 2 | 2004 | 1484 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9144 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2005 | 758 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2009 | 1407 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 424 | 0.010 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 18112 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2004 | 908 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2005 | 1309 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1984 | 508 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 1456 | 0.010 |
Why?
|
| Presenilin-2 | 1 | 2001 | 106 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9410 | 0.010 |
Why?
|
| Alcoholism | 1 | 1991 | 1904 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2009 | 1807 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 2007 | 5867 | 0.010 |
Why?
|
| Liposomes | 1 | 2004 | 758 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 329 | 0.010 |
Why?
|
| Congo Red | 1 | 1999 | 47 | 0.010 |
Why?
|
| Amino Acid Sequence | 3 | 1996 | 13814 | 0.010 |
Why?
|
| Microspectrophotometry | 1 | 1999 | 4 | 0.010 |
Why?
|
| Organotechnetium Compounds | 1 | 1999 | 137 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 9846 | 0.010 |
Why?
|
| Rod Cell Outer Segment | 1 | 1999 | 56 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 2500 | 0.010 |
Why?
|
| Rod Opsins | 1 | 1999 | 111 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2001 | 611 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 2915 | 0.010 |
Why?
|
| Rhodopsin | 1 | 1999 | 203 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 363 | 0.010 |
Why?
|
| Phagosomes | 1 | 1999 | 193 | 0.010 |
Why?
|
| Fluorometry | 1 | 1996 | 106 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4751 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1999 | 565 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2335 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 1996 | 112 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1996 | 202 | 0.010 |
Why?
|
| Cathepsin D | 1 | 1995 | 61 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4414 | 0.010 |
Why?
|
| Cathepsin B | 1 | 1995 | 82 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3920 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1999 | 463 | 0.010 |
Why?
|
| Lung | 1 | 1994 | 9826 | 0.010 |
Why?
|
| Alanine | 1 | 1997 | 572 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1996 | 489 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1996 | 434 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1996 | 430 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1107 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1995 | 410 | 0.010 |
Why?
|
| Genomic Library | 1 | 1994 | 193 | 0.010 |
Why?
|
| Autopsy | 1 | 1997 | 1006 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 1574 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12220 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1994 | 374 | 0.010 |
Why?
|
| Sweden | 1 | 1995 | 1343 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15494 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1994 | 462 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1994 | 537 | 0.010 |
Why?
|
| Pia Mater | 1 | 1992 | 88 | 0.010 |
Why?
|
| Karyotyping | 1 | 1994 | 1243 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 35342 | 0.010 |
Why?
|
| Arterioles | 1 | 1992 | 253 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1997 | 1167 | 0.010 |
Why?
|
| Introns | 1 | 1994 | 991 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1996 | 1086 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1996 | 2203 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 1999 | 2658 | 0.010 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 1991 | 314 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 13029 | 0.010 |
Why?
|
| Headache | 1 | 1997 | 1219 | 0.010 |
Why?
|
| Pedigree | 1 | 1997 | 4646 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1994 | 2003 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 2645 | 0.010 |
Why?
|
| Exons | 1 | 1994 | 2431 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 8829 | 0.000 |
Why?
|
| Atrophy | 1 | 1991 | 1576 | 0.000 |
Why?
|
| Organ Size | 1 | 1991 | 2253 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1994 | 4742 | 0.000 |
Why?
|
| HIV Infections | 1 | 1991 | 16678 | 0.000 |
Why?
|
| HIV | 1 | 1991 | 1600 | 0.000 |
Why?
|
| Base Sequence | 1 | 1994 | 12797 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1992 | 3744 | 0.000 |
Why?
|
| Kidney | 1 | 1995 | 7167 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1999 | 25575 | 0.000 |
Why?
|